Tuesday, March 10, 2026
ADVT 
International

US embassy in Saudi Arabia hit by Tehran's drones; Israel, US continue pounding Iran

Darpan News Desk IANS, 03 Mar, 2026 11:30 AM
  • US embassy in Saudi Arabia hit by Tehran's drones; Israel, US continue pounding Iran

As the war continued unrelentingly, Iran's drone hit the US Embassy in Saudi Arabia on Tuesday leading to its closure while the US and Israel continued to pound targets across Iran.

Saudi Arabia's Defence Ministry said that two drones hit the Embassy damaging it slightly, and there were no reports of casualties.

On Monday, the Washington's Embassy in Kuwait was also hit and it has been closed.

Meanwhile, the US asked its citizens to leave 14 countries across the Middle East, from Egypt to Yemen as threats heightened on the fourth day of the war.

Fox News, quoting a senior Israeli official, reported that it had struck an Iranian Supreme Council meeting on Tuesday to choose a successor to Ayatollah Ali Khamenei, who was killed on February 28 when the conflict began.

It was not known if there were casualties in the attack on the Iran complex.

US Under Secretary of War Elbridge Colby testifying before the Senate Armed Services Committee on Tuesday appeared to distance Washington from the killing of Khamenei.

He said that it was an Israeli operation while the US was focused on destroying Iran's military capacity.

Extending its arc of attacks, Israel bombed targets in Beirut associated with the Hezbollah, which had launched rocket attacks on Israel.

The Israeli troops also captured more territories in Southern Lebanon.

In a sign that the attacks would be extending, Israel's military warned Iranians through social media posts of imminent attacks in several places, including two areas in Tehran, and asked them to evacuate.

The toll in the war continued to rise, crossing the 1,000-mark across the region.

The Iranian Red Crescent reported that nearly 790 people have been killed, Lebanon put the toll there at 31, Israel reported 10, and Gulf countries six, in addition to the six American military personnel.

Picture Courtesy: IANS

MORE International ARTICLES

Extra safety scrutiny planned as virus vaccine worries grow

Extra safety scrutiny planned as virus vaccine worries grow
The poll from The Associated Press-NORC Center for Public Affairs Research found only 46% of Americans want a COVID-19 vaccine and another 29% are unsure.

Extra safety scrutiny planned as virus vaccine worries grow

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout
The COLA affects the personal finances of about 1 in 5 Americans, including Social Security recipients, disabled veterans and federal retirees, some 70 million people in all.

Retiree checks to rise 1.3% in 2021 amid coronavirus fallout

AP-NORC poll: New angst for caregivers in time of COVID-19

AP-NORC poll: New angst for caregivers in time of COVID-19
The Associated Press-NORC Center for Public Affairs Research poll finds that 17% of Americans say they are providing ongoing caregiving, part of an informal volunteer corps.

AP-NORC poll: New angst for caregivers in time of COVID-19

Am I immune to the coronavirus if I’ve already had it?

Am I immune to the coronavirus if I’ve already had it?
Reinfection so far has been rare. The best known example: Researchers in Hong Kong said a man had mild COVID-19 and then months later was infected again but showed no symptoms.

Am I immune to the coronavirus if I’ve already had it?

Antibody drugs are no cure but seem promising for COVID-19

Antibody drugs are no cure but seem promising for COVID-19
Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help it be eliminated. Vaccines mimic an infection to spur antibody production.

Antibody drugs are no cure but seem promising for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19

Lilly seeks emergency use of its antibody drug for COVID-19
Eli Lilly and Company announced the partial results Wednesday in a news release; they have not yet been published or reviewed by independent scientists.

Lilly seeks emergency use of its antibody drug for COVID-19